Efficacy of Nebulised Beclometasone in Viral Wheezing Prophylaxis
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Inhaled steroids, in particular beclomethasone, are widely prescribed in Italy as symptomatic
treatment of upper respiratory infections without evidence of efficacy.
The purpose of this study is to evaluate the efficacy of beclomethasone (administered by
nebuliser twice a day) in preventing viral wheezing in pre-school children who had had
episodes in the preceding 12 months.
Phase:
Phase 4
Details
Lead Sponsor:
Mario Negri Institute for Pharmacological Research
Collaborators:
Agenzia Italiana del Farmaco Associazione Culturale Pediatri